Novo Nordisk (NVO) Stock Price
$59.17 6.6%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
8 -
Technical
4
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Novo Nordisk, AI stock picks, stock alerts and much more.
NVO AI Stock Analysis
Financial Performance
Novo Nordisk has shown strong financial performance in the last quarter with revenue up by 20.2% from the previous quarter and up by 31.1% year over year to $85.7B. The gross profit also increased significantly, up by 21.1% from the previous quarter and up by 31.1% year over year to $72.7B, indicating a healthy margin expansion for the company.
The operating income was at $36.7B, showing an increase of 8.3% from the previous quarter and a rise of 13.3% YoY, which suggests efficient operations management within the company.
The EBITDA ratio stood at a decent level of .47 implying that Novo Nordisk is generating satisfactory earnings before interest, tax, depreciation and amortization.
Stock Price
The stock price has been on a downward trend as it's currently trading at $47.28, down -29.7% in the last month and -62.5% YoY which might raise concerns among investors regarding its short-term performance.
However, technical indicators such as RSI value (22.75) suggest that the stock could be oversold and may rebound soon while its PE ratio stands at 12.95 which indicates reasonable valuation levels compared to its earnings per share (EPS) of $3.65.
Alternative Data Signals
Negative trends are observed when looking at alternative data signals such as website traffic which is down by -6..3%, MoM and -20.% YoY along with job postings that have decreased by -13.% MoM and -18.% YoY.
However, the company shows strong social media presence with increasing followers across Twitter, Instagram and Facebook. The employee business outlook remains quite positive at 81%, despite a slight decrease YoY.
Conclusion
In conclusion, despite the short-term decline in stock price and some negative trends in alternative data signals like website traffic and job postings, Novo Nordisk's strong financial performance, reasonable valuation levels and positive business outlook suggest that it has potential for recovery making its stock neutral from an investment perspective.
Note: This AI Stock Analysis is based on data as of August 05. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Novo Nordisk (NVO) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Novo Nordisk (NVO), currently trading at $59.17, will... Sign up to access price prediction.
About NVO
-
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide.
-
Symbol
NVO
-
Market
NYSE
-
Industry
Biotechnology
-
Market Cap
262.9B
Similar Stocks
 |
Zymeworks ZYME |
$16.94 0.8% |
6 |
 |
Ginkgo Bioworks Holdings DNA |
$14.67 0.6% |
4 |
 |
Arcus Biosciences RCUS |
$13.48 0.9% |
5 |
News
NVO Alternative Data
Web Traffic
Novo Nordisk receives an estimated 736226 monthly visitors to novonordisk.com.
-
Web Traffic
736226
-
Change from Previous Month
3.8%
-
3 Month Change
21.8%
-
YoY Change
21.8%
Twitter Followers
Novo Nordisk has 52,738 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.8% over the last month.
-
Twitter Followers
52738
-
Daily Change
0%
-
1 Month Change
0.8%
-
3 Month Change
2.9%
-
YoY Change
2.9%
Facebook Engagement
Novo Nordisk has engaged 36,260 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
36260
-
Daily Change
6.8%
-
1 Month Change
39.3%
-
3 Month Change
14.2%
-
YoY Change
14.2%
Instagram Followers
Novo Nordisk has 153,831 Instagram Followers on its main Instagram account, up by 2.2% over the last month.
-
Instagram Followers
153831
-
Daily Change
0.1%
-
1 Month Change
2.2%
-
3 Month Change
4.9%
-
YoY Change
4.9%
Youtube Subscribers
Novo Nordisk has 42,900 subscribers on its main Youtube channel, up by 2.1% over the last month.
-
Youtube Subscribers
42900
-
Daily Change
0.2%
-
1 Month Change
2.1%
-
3 Month Change
3.9%
-
YoY Change
3.9%
Job Postings
Novo Nordisk has an estimated 69 open job postings, which is down -73.4% over the last month.
-
Job Postings
69
-
Daily Change
1.5%
-
1 Month Change
73.4%
-
3 Month Change
91.2%
-
YoY Change
91.2%
LinkedIn Employees
According to LinkedIn, Novo Nordisk has 67,462 employees, up by 0.8% over the last month.
-
LinkedIn Employees
67462
-
Daily Change
0%
-
1 Month Change
0.8%
-
3 Month Change
1.9%
-
YoY Change
1.9%
Reddit Mentions
Novo Nordisk has been mentioned an estimated 37 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
37
-
Daily Change
26%
-
1 Month Change
516.7%
-
3 Month Change
362.5%
Reddit Sentiment
The sentiment Score for Novo Nordisk is 55 out of 100, which represents a neutral sentiment.
-
Reddit Sentiment
54.85
-
Daily Change
10.4%
-
1 Month Change
24.2%
-
3 Month Change
15.9%
Business Outlook
According to employee reviews, the business outlook among employees at Novo Nordisk is 77 out of 100 (bullish).
-
Business Outlook
77
-
Change from Previous Month
3.8%
-
3 Month Change
4.9%
-
YoY Change
4.9%
LinkedIn Followers
2,310,547 are following Novo Nordisk on LinkedIn.
-
LinkedIn Followers
2310547
-
1 Month Change
0%
-
3 Month Change
0%
News Mentions
Novo Nordisk was mentioned 14 times in the news yesterday.
-
News Mentions
14
-
Daily Change
12.5%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
NVO Financials
NVO Key Metrics
-
Total Revenue
DKK85.7B
-
Net Income
DKK28.2B
-
Earnings per Share
DKK6.34
-
Free cash flow
-DKK4.3B
-
EBITDA
DKK40.1B
-
EBITDA Ratio
0.468494
-
Total Assets
DKK465.8B
NVO 2-year Revenue & Income
NVO 2-year Free Cash Flow
NVO Technicals
NVO SMA
NVO RSI
FAQ
What's the current price of Novo Nordisk (NVO) Stock?
The price of an Novo Nordisk (NVO) share is $59.17.
What's the market cap of Novo Nordisk?
The current market cap of Novo Nordisk is 262.9B.
What are some stocks similar to Novo Nordisk (NVO) that investors often compare it to?
Novo Nordisk (NVO) is often compared to similar stocks such as Zymeworks, Ginkgo Bioworks Holdings and Arcus Biosciences.
What is the forecast for Novo Nordisk's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Novo Nordisk's stock price to be around $60.48 in 2026. Starting from the current price of $59.17, this represents a 2.2% change in price, indicating a neutral outlook for the stock.
How to buy Novo Nordisk (NVO) Stock?
Novo Nordisk stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Novo Nordisk shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.